PTC Inc Faces Investor Warnings Amid Stock Decline and Drug Development Setbacks
PTC Inc. has faced a tumultuous year, marked by a significant stock price decline, investor warnings, and setbacks in its pharmaceutical ventures, including a failed Huntington’s disease drug.
3 minutes to read